Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Experimental Intraosseous vancomycin 500mg in 250 mL NS
Standard IV administration of vancomycin
Locations
1
United States
Houston Methodist Hospital
Houston, Texas, United States
Start Date
December 31, 2019
Primary Completion Date
May 25, 2022
Completion Date
September 1, 2022
Last Updated
March 13, 2025
NCT07406893
NCT02456974
NCT06426836
NCT06955481
NCT05169229
NCT06062251
Lead Sponsor
The Methodist Hospital Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions